E
Editas Medicine, Inc. EDIT
$4.08 -$0.075-1.81% NASDAQ
Recommendation
Prev Close
$4.15
Volume
2,232,265
Avg Vol (90D)
2,546,459
Market Cap
$373.17M
Dividend & Yield
--
52-Week Range
$0.9101 - $4.54
P/E (TTM)
--
EPS (TTM)
-$2.85
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of ...
10/9/2025 - GuruFocus
Editas Medicine (EDIT) Showcases Promising Preclinical Data for LDL Reduction
10/9/2025 - GuruFocus
Editas Medicine reports in vivo preclinical PoC data for EDIT-401
10/9/2025 - TipRanks Financial Blog
Editas Medicine reports in vivo preclinical PoC data for EDIT-401
10/9/2025 - The Fly
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
10/9/2025 - Globe Newswire
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell ...
10/6/2025 - GuruFocus
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
10/6/2025 - Globe Newswire
While institutions invested in Editas Medicine, Inc. (NASDAQ:EDIT) benefited from last week's 11% gain, individual investors stood to gain the most
10/6/2025 - Simply Wall St
EDIT Crosses Above Average Analyst Target
10/3/2025 - ETF Channel
Editas Medicine (EDIT, $3.89) price may drop as it broke higher Bollinger Band on Oct 02, 2025
10/3/2025 - Tickeron - Stocks
Editas Medicine (EDIT, $3.55) RSI Indicator left the overbought zone on October 01, 2025
10/2/2025 - Tickeron - Stocks
Editas Medicine, Inc. (NASDAQ:EDIT) Given Average Recommendation of "Hold" by Brokerages
10/2/2025 - Ticker Report
Editas Medicine (EDIT, $3.47) RSI Indicator left the overbought zone on September 30, 2025
10/1/2025 - Tickeron - Stocks
Editas Medicine (EDIT, $3.52) price may drop as it broke higher Bollinger Band on Sep 29, 2025
9/30/2025 - Tickeron - Technical Analysis
Editas Medicine (EDIT, $3.52) RSI Indicator left the overbought zone on September 29, 2025
9/30/2025 - Tickeron - Technical Analysis
Peek Under The Hood: NXTE Has 11% Upside
9/29/2025 - ETF Channel
Editas Medicine (NASDAQ:EDIT) Upgraded by Wall Street Zen to Hold Rating
9/27/2025 - MarketBeat
Editas Medicine (EDIT, $3.23) RSI Indicator left the overbought zone on September 25, 2025
9/26/2025 - Tickeron - Technical Analysis
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
9/25/2025 - CNW Group - News Releases
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
9/25/2025 - PR Newswire
Editas Medicine (EDIT, $3.37) RSI Indicator left the overbought zone on September 24, 2025
9/25/2025 - Tickeron - Stocks
Editas Medicine (EDIT, $3.37) price may drop as it broke higher Bollinger Band on Sep 24, 2025
9/25/2025 - Tickeron - Stocks
Editas Medicine, Inc. (NASDAQ:EDIT) Given Average Recommendation of "Hold" by Analysts
9/25/2025 - MarketBeat
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
9/9/2025 - Simply Wall St
Editas Medicine, Inc. $EDIT Shares Bought by Ieq Capital LLC
9/9/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$38.90M
EBITDA (TTM)
-$154.07M
EBIT (TTM)
-$160.80M
Net Income (TTM)
-$236.86M
Balance Sheet
Total Assets (Q)
$210.58M
Total Debt (Q)
$21.14M
Total Liabilities (Q)
$191.39M
Book Value Per Share (Q)
$0.2196
Cash Flow
Cash from Operations (TTM)
-$201.36M
Cash from Investing (TTM)
$213.97M
Cash from Financing (TTM)
$61.49M
Net Change in Cash (TTM)
$74.10M
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
2.46
7-Day Total Return
17.29%
30-Day Total Return
52.43%
60-Day Total Return
43.31%
90-Day Total Return
129.94%
Year to Date Total Return
210.69%
1-Year Total Return
30.45%
2-Year Total Return
-41.94%
3-Year Total Return
-65.51%
5-Year Total Return
-87.70%
52-week Low
Apr 07, 2025 - $0.9101
52-week High
Oct 08, 2025 - $4.54
Valuation
Market Cap
$373.17M - Small Cap
Enterprise Value
$215.80M
Price/Sales (TTM)
9.01
Price/Book (Q)
18.90
Dividends and Shares
Shares Outstanding
84.41
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.editasmedicine.com
Phone Number
617 401 9000
Address
11 Hurley Street
Cambridge, MA 02141
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary... more
NASDAQ 10/09/2025 3:11PM Eastern Quotes delayed